FDA Adverse Event Injury Summary report: N

NEUWAVE PR PROBE 20CM 17GA

MDR report key: 8428998 · Received March 18, 2019

Report

Report Number
3008769756-2019-00024
Event Type
Injury
Date Received
March 18, 2019
Report Date
February 22, 2019
Manufacturer
NEUWAVE MEDICAL, INC.
Product Code
NEY
UDI-DI
00853719006418
PMA / PMN Number
K160936
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT # (B)(4). THE LOT WAS NOT PROVIDED; THEREFORE, A MANUFACTURING RECORD EVALUATION COULD NOT BE PERFORMED.

Description of Event or Problem · 1

IT WAS REPORTED VIA LITERATURE ENTITLED: MICROWAVE ABLATION OF OSTEOID OSTEOMA: SAFETY AND EFFICACY. AUTHOR(S): V. GIOIOSO, S. REIS, S. BREJT, S. TULIN-SILVER, D. SPERLING, J. SUSMAN, J. WEINTRAUB, D. MOBLEY. CITATION: JVIR SCIENTIFIC E-POSTERS; S243. THE PURPOSE OF THIS STUDY WAS TO EVALUATE THE SAFETY AND EFFICACY OF CT-GUIDED MICROWAVE ABLATION (MWA) OF OSTEOID OSTEOMAS. FROM 2014 TO 2017, 24 PATIENTS UNDERWENT MWA FOR OSTEOD OSTEOMAS. A SINGLE PR MICROWAVE ANTENNA ABLATION PROBE (NEUWAVE MEDICAL) WAS PLACED IN A COAXIAL MANNER INTO THE NIDUS. SERIAL MICROWAVE ABLATIONS WERE PERFORMED, PER PROTOCOL. COMPLICATION INCLUDED PROBE FRACTURING IN THE LESION DURING POSITIONING REQUIRED SURGICAL REMOVAL OF THE PROBE TIP AS WELL AS THE OSTEOID OSTEOMA DUE TO CONTINUED PAIN. THERE WERE NO DOCUMENTED POSTPROCEDURAL COMPLICATIONS OF POST BIOPSY OR POST-MWA HEMATOMA OR INFECTION CT-GUIDED MICROWAVE ABLATION IS A WELL-TOLERATED, SAFE AND EFFECTIVE TREATMENT OF OSTEOID OSTEOMA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
223606 NEUWAVE PR PROBE 20CM 17GA SYSTEM, ABLATION, MICROWAVE AND ACCESSORIES NEY NEUWAVE MEDICAL, INC. 00853719006418

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention SYSTEM - NWC1US1N